CD4 and AIDS: On the other hand, by using CD4 cell count to guide intermittent therapy starting and stopping points, the National Institute of Health’s Strategies for Management of Antiretroviral Therapy (SMART) study[11], revealed that STI was associated with increased risk of AIDS or death, serious AIDS-defining events, and other severe complications.